Search

everythinglearnresearchcommunity

for

Search:↓

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A new platinum complex was made and studied, which might help fight cancer better.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Promising cancer treatments were found, but the manufacturer closed.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Alopecia is a key indicator of thallium poisoning.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

A new model helps predict treatment success in girls with early puberty.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Ritlecitinib is safe and may effectively treat alopecia areata.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Ovarian vein sampling can effectively locate ovarian tumors when imaging is unclear.

New steroids were effective in blocking male hormone receptors in hamster prostates.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Recognizing LET and AITD can help diagnose SLE early for better treatment.